Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Researchers evaluate retrospectively obtained health-related quality-of-life data from COVID-19 patients

Researchers evaluated retrospective EQ-5D-5L data collection among COVID-19 patients.

23 Jan 2023

Researchers estimate COVID-19 Omicron variant mortality in Denmark

A recent Eurosurveillance study investigated how coincidental infections influenced COVID-19 mortality estimates after the emergence of the Omicron variant.

23 Jan 2023

What was the prevalence of adverse events following first and second dose COVID-19 vaccinations in England?

A recent Eurosurveillance study focused on estimating the incidence of a prespecified list of adverse events following the first and second doses of the COVID-19 vaccination.

23 Jan 2023

Bivalent BA.4-5 or BA.1 mRNA-booster given as a fourth dose associated with increased protection against COVID-19 hospitalization and death

Researchers compared the efficiency of the SARS-CoV-2 Omicron BA.4-5 and BA.1 bivalent mRNA-booster vaccines.

23 Jan 2023

Study suggests Alzheimer’s disease diagnosis is associated with higher levels of soluble ACE2 in the human brain

Researchers investigated ACE2 (angiotensin-converting enzyme 2) levels among individuals with AD (Alzheimer’s disease).

23 Jan 2023

Potent small-molecule inhibitors against SARS-CoV, MERS-CoV, and SARS-CoV-2

In a recent study posted to bioRxiv* preprint server, researchers in the United States identified several potent pan-coronavirus (CoV) inhibitors.

23 Jan 2023

SARS-CoV-2 Omicron XBB.1.5, CA.3.1, and CH.1.1 exhibit remarkable antibody resistance

In a recent study posted to bioRxiv* preprint server, researchers at Ohio State University examined the degree of neutralizing antibody (nAb) evasion by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron XBB.1.5, CA.3.1, and CH.1.1 subvariants.

23 Jan 2023

Heart symptoms persist in 10% of patients with long-COVID

In a recent study posted to the medRxiv* preprint server, researchers described the long-term cardiac symptoms associated with coronavirus disease 2019 (COVID-19).

22 Jan 2023

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

In a recent study published in The Lancet Microbe journal, researchers described the effectiveness of a modular capsid virus-like coronavirus disease 2019 (COVID-19) vaccination.

22 Jan 2023

Senolytics could be a beneficial therapeutic for COVID neuropathology

Researchers assess the effectiveness of multiple senolytic interventions in removing senescent cells in aged human brain organoids.

22 Jan 2023

Borrowing from weather and climate science models can help us prepare for future pandemics

A new study determines how insights from the climate and weather research field can improve the forecasting of pandemics.

22 Jan 2023

First known epidemic of highly pathogenic avian influenza H5N1 in farmed mink

Highly pathogenic avian influenza (HPAI) A(H5N1) is a strain of the avian influenza virus that primarily affects birds, particularly poultry. HPAI A(H5N1) is a highly contagious and deadly virus that can cause severe illness and death in birds, including chickens, ducks, geese, and turkeys.

22 Jan 2023

People with hybrid immunity are the most protected against severe COVID-19 and reinfection

A University of Calgary research group - which includes several Bachelor of Health Sciences alumni joined forces with members of the World Health Organization to tackle a global health question.

20 Jan 2023

Analysis of seemingly recovered COVID-19 patients indicates that SARS-CoV-2 infection can persist significantly longer than suggested by PCR-negative tests

Scientists have described the infection dynamics and clinical features of PCR-negative patients who eventually died due to the worsening of COVID-19.

20 Jan 2023

Longitudinal assessment of immunoglobulin G antibody responses to messenger ribonucleic acid vaccination doses and breakthrough infections

Researchers evaluated immunoglobulin G (IgG) responses to coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA) vaccinations.

20 Jan 2023

How effective are prior SARS-CoV-2 infections and hybrid immunity against Omicron breakthrough infections?

Researchers performed a systematic review and meta-regression study to determine the breadth and duration of the protective immunity conferred by previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and hybrid immunity.

20 Jan 2023

Study shows increase in medical encounters six months post-SARS-CoV-2 infection, with vaccination lowering persistent symptoms risk

Researchers identified factors related to PCC [post-COVID-19 (coronavirus disease 2019] symptoms and assessed changes in PCC medical visits.

20 Jan 2023

A cut-off score can accurately identify individuals with high levels of fear about COVID-19

The coronavirus disease 2019 (COVID-19) pandemic has had profound effects, both globally and on a highly personal level. Now, researchers from Japan have developed an accurate way of assessing the effects of the pandemic on our emotional health and wellbeing.

20 Jan 2023

New trial evaluates Omicron BA.1–adapted BNT162b2 vaccine in older adults

Researchers reported the findings of the phase III trial evaluating the Omicron BA.1–adapted mono and bivalent BNT162b2 coronavirus disease 2019 (COVID-19) vaccine in 55-year-old adults. These individuals had already received three 30μg doses of the BNT162b2 vaccine.

20 Jan 2023

WHO to launch council to accelerate the development of TB vaccine

The World Health Organization announces the creation of the TB Vaccine Accelerator Council.

20 Jan 2023

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Researchers evaluate retrospectively obtained health-related quality-of-life data from COVID-19 patients

Researchers estimate COVID-19 Omicron variant mortality in Denmark

What was the prevalence of adverse events following first and second dose COVID-19 vaccinations in England?

Bivalent BA.4-5 or BA.1 mRNA-booster given as a fourth dose associated with increased protection against COVID-19 hospitalization and death

Study suggests Alzheimer’s disease diagnosis is associated with higher levels of soluble ACE2 in the human brain

Potent small-molecule inhibitors against SARS-CoV, MERS-CoV, and SARS-CoV-2

SARS-CoV-2 Omicron XBB.1.5, CA.3.1, and CH.1.1 exhibit remarkable antibody resistance

Heart symptoms persist in 10% of patients with long-COVID

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

Senolytics could be a beneficial therapeutic for COVID neuropathology

Borrowing from weather and climate science models can help us prepare for future pandemics

First known epidemic of highly pathogenic avian influenza H5N1 in farmed mink

People with hybrid immunity are the most protected against severe COVID-19 and reinfection

Analysis of seemingly recovered COVID-19 patients indicates that SARS-CoV-2 infection can persist significantly longer than suggested by PCR-negative tests

Longitudinal assessment of immunoglobulin G antibody responses to messenger ribonucleic acid vaccination doses and breakthrough infections

How effective are prior SARS-CoV-2 infections and hybrid immunity against Omicron breakthrough infections?

Study shows increase in medical encounters six months post-SARS-CoV-2 infection, with vaccination lowering persistent symptoms risk

A cut-off score can accurately identify individuals with high levels of fear about COVID-19

New trial evaluates Omicron BA.1–adapted BNT162b2 vaccine in older adults

WHO to launch council to accelerate the development of TB vaccine

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in